bimoxyl vet 150 mg/ml injektioneste, suspensio
laboratorios maymo, s.a - amoxicillin trihydrate - injektioneste, suspensio - 150 mg/ml - amoksisilliini
opamox 15 mg tabletti
orion corporation - oxazepam - tabletti - 15 mg - oksatsepaami
opamox 50 mg tabletti
orion corporation - oxazepam - tabletti - 50 mg - oksatsepaami
opamox 30 mg tabletti
orion corporation - oxazepam - tabletti - 30 mg - oksatsepaami
candemox 4 mg tabletti
sandoz a/s - candesartan cilexetil - tabletti - 4 mg - kandesartaani
candemox 8 mg tabletti
sandoz a/s - candesartan cilexetil - tabletti - 8 mg - kandesartaani
candemox 16 mg tabletti
sandoz a/s - candesartan cilexetil - tabletti - 16 mg - kandesartaani
candemox 32 mg tabletti
sandoz a/s - candesartan cilexetil - tabletti - 32 mg - kandesartaani
candemox comp 16 mg / 12,5 mg tabletti
sandoz a/s - hydrochlorothiazide, candesartan cilexetil - tabletti - 16 mg / 12,5 mg - kandesartaani ja diureetit
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - budesonidi / formoterol teva pharma b. on tarkoitettu aikuisille vain 18-vuotiaille ja vanhemmille. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.